Heart Failure Summit
- Continuing Education
Explore comprehensive, multidisciplinary strategies for managing heart failure—from outpatient care to advanced therapies—through expert-led sessions, case studies, and patient perspectives in this Harvard Medical School–accredited one-day summit.
On This Page
Overview
Heart Failure Summit, accredited by Harvard Medical School, will offer a one-day overview of all aspects of heart failure management from outpatient monitoring to left ventricular assist device implantation and cardiac transplantation. Faculty from multiple disciplines will review current guidelines and potential therapies for advanced heart failure. The course will provide case studies illustrating different approaches to pharmacological and device management. Participants will also hear patient and caregiver perspectives on therapies for advanced heart failure.
Learning Objectives
- Outline current outpatient management strategies for advanced heart failure including novel pharmacologic treatments, home monitoring, and advanced care planning.
- Review current pharmacologic approaches to treatment and their practical implementation in patients with cardiomyopathy.
- Discuss representative case examples to demonstrate the use of mechanical support, including ventricular assist devices (VADs) to improve survival and quality of life as a bridge to transplant (BTT) or destination therapy (DT).
- Review innovative techniques, surgical considerations, and expected outcomes for patients undergoing heart transplantation.
- Share patient and caregiver perspectives on living with advanced heart failure.
Developed and Offered By:
Who Should Participate
Specialty Physicians, Nurse Practitioners, Nurses, Pharmacists, Primary Care Physicians, Physician Assistants, Physical therapists, Nutritionists, Trainees (residents and fellows), and other health care professionals
Schedule
Friday, January 30, 2026
Current State of Advanced Heart Failure
8:30-8:50 am
Advanced Heart Failure: Surgical Options
8:50-9:05 am
Treatment of Antibody-Medicated Rejection
9:05-9:20 am
Q&A
9:20-9:30 am
Break #1
9:30-9:50 am
Treating Heart Failure Symptoms in Hypertrophic Cardiomyopathy
9:50-10:10 am
Updates in Physiologic Pacing
10:10-10:25 am
Cardiac Contractility Modulation
10:25-10:40 am
Q&A
10:40-10:50 am
Break #2
10:50-11:10 am
Case Studies: Complications in Heart Transplant and MCS
11:10 am-12:10 pm
Lunch break
12:10-1:10 pm
Patient Panel Discussion
1:10-2:10 pm
Break
2:10-2:30 pm
Beyond GDMT: Novel therapies for Infiltrative Cardiomyopathies
2:30-3:30 pm
Deep Dive into MCS Hemodynamics
2:30-3:30 pm
Faculty
Harvard Medical School Continuing Education attracts the best and brightest faculty from all around the world. As a student in this course, you’ll have access to outstanding course directors and faculty.
Course Directors
Marwa Sabe
MD, MPH, FACC | Course Director
- Associate Director, Section of Advanced Heart Failure, MCS, and Heart Transplant
- Director, Ventricular Assist Device Program, Beth Israel Deaconess Medical Center
David Venesy
MD | Course Director
- Director, Advanced Heart Failure and Cardiomyopathy Program, Lahey Hospital & Medical Center
Lisa Fleming
MD, MPH | Course Director
- Advanced Heart Failure and Transplant Cardiologist, Atrius Health
Dana Price
MD | Course Director
- Advanced Heart Failure and Transplant Cardiologist, Lahey Hospital & Medical Center
Cecilia Berardi, MD
Heart Failure and Transplantation Cardiologist, Baystate Health
Daniel Burkhoff, MD, PhD
Director of Heart Failure, Hemodynamics and MCS Research, CFS
Gina Deigan, PA
Physician's Assistant, Advanced Heart Failure and Cardiomyopathy Program, Lahey Hospital & Medical Center
Amy French, MD
Cardiologist, Advanced Heart Failure and Cardiomyopathy Program, Lahey Hospital & Medical Center
Shannon Frias, RN
Heart Transplant Program, Nurse Coordinator, Beth Israel Deaconess Medical Center
A. Reshad Garan, MD, MS, FACC
Section Chief, Advanced Heart Failure, Cardiac Transplant, and MCS, Beth Israel Deaconess Medical Center
E. Wison Grandin, MD, MPH, MEd
Director, ECMO and Temporary MCS, Beth Israel Deaconess Medical Center
Masashi Kai, MD
Surgical Director, Heart Transplant Program, Beth Israel Deaconess Medical Center
Sonia Kothari, PharmD, BCPS, BCCP
Clinical Pharmacy Specialist, Beth Israel Deaconess Medical Center
Joyce Larson, DNP, ANP-BC
Nurse Practitioner, BIDMC Hypertrophic Cardiomyopathy Clinic
Pablo Quintero, MD
Medical Director, Heart Transplant Program, Beth Israel Deaconess Medical Center
Ethan Rowin, MD
Associate Director, Hypertrophic Cardiomyopathy Center, Lahey Hospital & Medical Center
Roy Sriwattanakomen, MD
Heart Failure and Transplantation Cardiologist, UPMC
Amanda Stoker, RN
Heart Transplant Program, Nurse Coordinator, Beth Israel Deaconess Medical Center
Yusuke Tsukioka, MD, MPH
Cardiac Surgeon, Beth Israel Deaconess Medical Center
Patricia Tung, MD
Cardiac Electrophysiologist, Beth Israel Deaconess Medical Center
Request Information
Interested in learning more about this program? Sign up for details.
Course Fees
Fee Disclaimer
You may register through our secure online environment and will receive an email confirmation upon receipt of your payment. Prices include CME credit, electronic syllabus. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
| Role | Course Fee |
|---|---|
| Physician (MD/DO) | $100.00 |
| Nurse (RN/APRN) | $50.00 |
| PA | $50.00 |
| Social Worker | $50.00 |
| Allied Health Professional / Other | $50.00 |
BILH Residents and fellows can attend for free, contact CardioVascularInstitute@bidmc.harvard.edu for more info.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 4.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Harvard Medical School designates this live activity for a maximum of 4.75 ANCC contact hours, of which 4.75 is eligible for pharmacology credit.
Harvard Medical School has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Harvard Medical School designates this knowledge-based activity for a maximum of 4.75 hours. Credit will be provided to NABP CPE Monitor within 60 days after the activity completion. UAN#:
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.